Stephens Inc. AR Purchases 842 Shares of National Health Investors, Inc. $NHI

Stephens Inc. AR increased its position in shares of National Health Investors, Inc. (NYSE:NHI) by 10.8% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,662 shares of the real estate investment trust’s stock after buying an additional 842 shares during the period. Stephens Inc. AR’s holdings in National Health Investors were worth $607,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Smartleaf Asset Management LLC raised its stake in National Health Investors by 49.8% during the first quarter. Smartleaf Asset Management LLC now owns 442 shares of the real estate investment trust’s stock worth $33,000 after buying an additional 147 shares during the last quarter. NewEdge Advisors LLC raised its stake in National Health Investors by 28.7% during the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock worth $114,000 after buying an additional 345 shares during the last quarter. Jupiter Asset Management Ltd. bought a new position in National Health Investors during the first quarter worth $206,000. Xponance Inc. increased its stake in National Health Investors by 11.2% in the first quarter. Xponance Inc. now owns 3,334 shares of the real estate investment trust’s stock valued at $246,000 after purchasing an additional 337 shares in the last quarter. Finally, Monument Capital Management bought a new stake in National Health Investors in the second quarter valued at $252,000. Institutional investors own 62.51% of the company’s stock.

National Health Investors Stock Down 0.2%

NHI opened at $75.20 on Friday. The company has a quick ratio of 10.91, a current ratio of 10.91 and a debt-to-equity ratio of 0.75. The stock has a market cap of $3.57 billion, a price-to-earnings ratio of 24.03, a PEG ratio of 3.38 and a beta of 0.77. National Health Investors, Inc. has a twelve month low of $65.13 and a twelve month high of $82.32. The company’s 50-day moving average price is $77.13 and its two-hundred day moving average price is $74.27.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.16 by $0.06. The company had revenue of $70.27 million for the quarter, compared to analysts’ expectations of $86.46 million. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. National Health Investors’s revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the company posted $1.18 EPS. As a group, equities analysts expect that National Health Investors, Inc. will post 4.41 earnings per share for the current year.

National Health Investors Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be issued a dividend of $0.92 per share. This is a boost from National Health Investors’s previous quarterly dividend of $0.90. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $3.68 dividend on an annualized basis and a yield of 4.9%. National Health Investors’s payout ratio is currently 117.57%.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on NHI shares. Cantor Fitzgerald started coverage on shares of National Health Investors in a research note on Wednesday, October 1st. They issued an “overweight” rating and a $90.00 price target for the company. Wells Fargo & Company lifted their price target on shares of National Health Investors from $76.00 to $80.00 and gave the company an “equal weight” rating in a research note on Wednesday, August 27th. National Bankshares set a $90.00 price target on shares of National Health Investors in a research note on Wednesday, October 1st. Wedbush raised shares of National Health Investors to a “strong-buy” rating in a research note on Wednesday, July 2nd. Finally, Weiss Ratings reaffirmed a “buy (b-)” rating on shares of National Health Investors in a research note on Saturday. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Buy” and an average target price of $84.83.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.